| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/21/2013 | US20130046020 Eicosapentaenoic acid concentrate |
| 02/21/2013 | US20130046019 Methods of Treatment Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production |
| 02/21/2013 | US20130046018 Dietary supplements containing terpenoid acids of maslinic acid or oleanolic acid and process for enhancing muscle mass in mammals |
| 02/21/2013 | US20130046016 Method for lowering cholesterol |
| 02/21/2013 | US20130046015 Therapeutic Inhibition of Granulocyte Function in Demyelinating Disease |
| 02/21/2013 | US20130046014 Pharmaceutical composition for treatment of increased intraocular pressure |
| 02/21/2013 | US20130046013 Salicylate fatty acid derivatives |
| 02/21/2013 | US20130046012 New compounds, synthesis and use thereof in the treatment of pain |
| 02/21/2013 | US20130046011 Hot-melt extruded compositions containing plant-derived phenolic materials and processes for the preparation thereof |
| 02/21/2013 | US20130046010 Sumo as a marker of cancer development and target for cancer therapy |
| 02/21/2013 | US20130046009 Rho kinase inhibitors for treatment of mastocytosis and acute myeloid leukemia |
| 02/21/2013 | US20130046008 Selective reduction of allelic variants |
| 02/21/2013 | US20130046007 Selective reduction of allelic variants |
| 02/21/2013 | US20130046006 Inhibitors of fam3b gene, inhibitor compositions, inhibiting methods and applications of inhibitors in preparing pharmaceuticals |
| 02/21/2013 | US20130046005 Treatment of immune disorders using kainate receptor antagonists |
| 02/21/2013 | US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/21/2013 | US20130046003 Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating retinal diseases |
| 02/21/2013 | US20130046001 Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration |
| 02/21/2013 | US20130046000 Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent |
| 02/21/2013 | US20130045999 Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof |
| 02/21/2013 | US20130045998 Process for preparing rufinamide intermediate |
| 02/21/2013 | US20130045997 Pirfenidone therapy and inducers of of cytochrome p450 |
| 02/21/2013 | US20130045996 Combination product for controlling parasites on animals |
| 02/21/2013 | US20130045994 Pyridine derivative |
| 02/21/2013 | US20130045993 Inhibitors of cyclin-dependent kinases and their use |
| 02/21/2013 | US20130045992 Compositions and Methods for Enhancing Proteasome Activity |
| 02/21/2013 | US20130045991 Neuroprotective modulation of nmda receptor subtype activities |
| 02/21/2013 | US20130045990 Novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes |
| 02/21/2013 | US20130045988 Combination therapy |
| 02/21/2013 | US20130045987 Novel methods of use of tetrahydroberberine (thb) |
| 02/21/2013 | US20130045986 Novel compounds as modulators of gpr-119 |
| 02/21/2013 | US20130045983 Hsp90 inhibitors for therapeutic treatment |
| 02/21/2013 | US20130045982 Benzamide derivatives |
| 02/21/2013 | US20130045981 Aripiprazole complex formulation and method |
| 02/21/2013 | US20130045980 Imidazopyridazinyl compounds |
| 02/21/2013 | US20130045979 Method of treating major depressive disorder |
| 02/21/2013 | US20130045978 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/21/2013 | US20130045977 TGF-beta SIGNAL TRANSDUCTION INHIBITOR |
| 02/21/2013 | US20130045976 Isoindoline compounds and methods of their use |
| 02/21/2013 | US20130045975 Bicyclic heteroaryl inhibitors of pde4 |
| 02/21/2013 | US20130045974 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors |
| 02/21/2013 | US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/21/2013 | US20130045972 Glucocorticoid receptor antagonists |
| 02/21/2013 | US20130045971 Induced hypothermia |
| 02/21/2013 | US20130045969 Plant disease controlling composition and method for controlling plant disease |
| 02/21/2013 | US20130045967 COMPOUNDS FOR MODULATING INTEGRIN CDIIb/CDI8 |
| 02/21/2013 | US20130045966 Method of Lowering Serum Uric Acid Levels With (S)-Tofisopam |
| 02/21/2013 | US20130045965 Inhibitors of bruton's tyrosine kinase |
| 02/21/2013 | US20130045964 Mandelamide heterocyclic compounds |
| 02/21/2013 | US20130045963 Cyclohexyl Azetidine Derivatives as JAK Inhibitors |
| 02/21/2013 | US20130045962 Peptide deformylase inhibitors |
| 02/21/2013 | US20130045960 Abuse-Deterrent Pharmaceutical Compositions of Opiods and Other Drugs |
| 02/21/2013 | US20130045959 Method for late post coital contraception using ulipristal acetate |
| 02/21/2013 | US20130045958 Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| 02/21/2013 | US20130045957 Prevention of and Recovery from Drug-Induced Ototoxicity |
| 02/21/2013 | US20130045956 Preventive and/or therapeutic agent of hand-foot syndrome |
| 02/21/2013 | US20130045955 Novel compounds |
| 02/21/2013 | US20130045953 Nestorone®/estradiol transdermal gel |
| 02/21/2013 | US20130045952 ABA Receptor Agonists for Increased Plant Stress Resistance |
| 02/21/2013 | US20130045951 Novel Nitroso Compounds as Nitroxyl Donors and Methods of Use Thereof |
| 02/21/2013 | US20130045950 Phosphonate Compounds |
| 02/21/2013 | US20130045949 Anti-cancer agents |
| 02/21/2013 | US20130045948 Azocyclic inhibitors of fatty acid amide hydrolase |
| 02/21/2013 | US20130045947 Pla2activity as a marker for ovarian and other gynecologic cancers |
| 02/21/2013 | US20130045946 Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved |
| 02/21/2013 | US20130045945 Treatment of Arthritis and Other Musculoskeletal Disorders With Crosslinked Hyaluronic Acid |
| 02/21/2013 | US20130045944 Anti-Cancer Therapies |
| 02/21/2013 | US20130045943 A3ar agonists for the treatment of uveitis |
| 02/21/2013 | US20130045942 N6-substituted adenosine derivatives and n6-substituted adenine derivatives and uses thereof |
| 02/21/2013 | US20130045941 Dimethyl sulfoxide (dmso) or dmso and methylsulfonylmethane (msm) formulations to treat infectious diseases |
| 02/21/2013 | US20130045940 Composition comprising as active ingredient l-carnitine in combination with a solar filter, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
| 02/21/2013 | US20130045939 Fatty acid macrolide derivatives and their uses |
| 02/21/2013 | US20130045938 Kinase modulators for the treatment of cancer |
| 02/21/2013 | US20130045937 Parenteral formulations of macrolide antibiotics |
| 02/21/2013 | US20130045936 Composition comprising an amorphous non-crystalline glass form of roxithromycin |
| 02/21/2013 | US20130045935 Flavonoid dimers and their use |
| 02/21/2013 | US20130045934 Extraction method using ultra fine bubbles and liquid extracts obtained thereof |
| 02/21/2013 | US20130045933 Aloe-emodin derivatives and use thereof for the treatment of cancer |
| 02/21/2013 | US20130045932 Retinoid topical compositions and methods for treating skin conditions |
| 02/21/2013 | US20130045931 Production and use of antibacterial, antiproliferative, and antiphytopathogenic benzanthracenes |
| 02/21/2013 | US20130045930 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 02/21/2013 | US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 02/21/2013 | US20130045520 Double-stranded oligonucleotides |
| 02/21/2013 | US20130045290 Dermal rejuvenation compositions and methods |
| 02/21/2013 | US20130045287 Treatment for Concussion using Gallium Compounds |
| 02/21/2013 | US20130045286 Pyrrolopyridines as kinase inhibitors |
| 02/21/2013 | US20130045283 Compositions for and methods of controlling olfactory responses to odorants |
| 02/21/2013 | US20130045276 Sustained release aminopyridine composition |
| 02/21/2013 | US20130045273 Methods for using nutritional supplements containing lipoic acids and sulfur containing compounds |
| 02/21/2013 | US20130045272 Agent for treating myelofibrosis |
| 02/21/2013 | US20130045271 Steroid hormone delivery systems and methods of preparing the same |
| 02/21/2013 | US20130045268 Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
| 02/21/2013 | US20130045267 Methods of using agents that modulate claudin expression |
| 02/21/2013 | US20130045257 Aerosol shave composition comprising a hydrophobical agent forming at least one microdroplet and an anti-irritation agent |
| 02/21/2013 | US20130045256 Shave preparations comprising an anti-irritation agent |
| 02/21/2013 | US20130045253 Oral antidepressant formulation with reduced excipient load |
| 02/21/2013 | US20130045251 Pharmaceutical composition for improving solubility of prasugrel and its preparation method |
| 02/21/2013 | US20130045250 Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative |
| 02/21/2013 | US20130045249 Glycosaminoglycans |
| 02/21/2013 | US20130045248 Personal care compositions comprising an anti-irritation agent |